yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45069581-02DA4557-2D94-49A3-ACB3-7BC2D4BD6CCC
Q45069581-02DA4557-2D94-49A3-ACB3-7BC2D4BD6CCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45069581-02DA4557-2D94-49A3-ACB3-7BC2D4BD6CCC
"Neurological complications of new chemotherapy agents".
P2860
Q45069581-02DA4557-2D94-49A3-ACB3-7BC2D4BD6CCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45069581-02DA4557-2D94-49A3-ACB3-7BC2D4BD6CCC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6b65801a5357ce9af23a06956ea9ec61489f3b60
P2860
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.